Ebola

Merck & Co Inc’s (NYSE:MRK) rVSV-ZEBOV vaccine is the only WHO-prequalified vaccine endorsed by the Strategic Advisory Group of Experts on Immunization for use in Ebola outbreaks caused by the Zaire ebolavirus. The FDA approved the vaccine for adults in December 2019 and for use in...

Recent storm conditions leading to flooding at the Burning Man festival have raised concerns about possible health risks, despite rumors of an Ebola outbreak being debunked, Insider reported. The festival site was hit with heavy rainfall, leading to muddy conditions and stranded attendees. Social...

Inovio Pharmaceuticals Inc (NASDAQ: INO) announced results from a Phase 1b trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.  Ervebo is an FDA-approved vaccine to prevent ebola in...

The U.S. sent Gilead Sciences Inc's (NASDAQ: GILD) remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda as a response to the Ebola outbreak. The medicines will help safeguard healthcare workers responding to an outbreak that has...

The World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics, with new recommendations for using two monoclonal antibodies.  Following a systematic review and meta-analysis, WHO recommended two monoclonal antibody treatments, Ebanga (...

Data from two papers published in The Lancet Infectious Diseases demonstrated that the Johnson & Johnson (NYSE: JNJ) Ebola vaccine regimen showed a long-lasting immune response. The regimen, which uses Zabdeno (Ad26.ZEBOV) for one shot, and Mvabea (MVA-BN-Filo) for the next...

The United States Food and Drug Administration approved Regeneron Pharmaceuticals, Inc's (NASDAQ: REGN) drug Inmazeb for the treatment of Ebola in both adults and children on Wednesday. What Happened: Inmazeb is the first-ever drug approved for the treatment of the infection caused by the...

Airlines, hotels, casinos and other stocks continue to fall as fear of the coronavirus grows worldwide and all but halts activity in the virus epicenter of Wuhan, China. One sector, in particular, could profit from the outbreak. Editor's note: This list has been updated since it was...

Johnson & Johnson (NYSE: JNJ) could play a role in fighting the coronavirus, but a vaccine could take up to a year to develop. What Happened Johnson & Johnson tasked dozens of scientists across the world to work on a vaccine for the fast-spreading coronavirus and the company is "pretty...

Hazard masks are already a hot commodity in China, but the novel coronavirus has heightened demand. Chinese mask manufacturers continue to blaze through orders, turning 20 million masks per day at max capacity and declining their traditional pause for Spring Festival, according to The Global Times...

Lakeland Industries, Inc. (NASDAQ: LAKE) closed Tuesday's trading session up 7.27 percent after the World Health Organization confirmed an Ebola outbreak in the Democratic Republic of the Congo. The producer of protective clothing isn’t guaranteed a significant sales boost, according to...

Cruise stocks have been red-hot this year, but seem to be flying under the radar. But investors should consider picking up a few of the cruise stocks, at least according to CNBC's Jim Cramer. Cramer explained during his daily "Mad Money" show that there has been a shift in sentiment...

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) said Thursday it’s observed a 100-percent antibody response in a phase I study for a Zika virus vaccine and a 92 percent antibody response in a phase I study for a MERS vaccine. The findings were presented at a Coalition for Epidemic Preparedness...

The question of how much power the government should exercise to keep Americans safe is a complicated and controversial issue; one that is the root of much of the conflict arising since President Donald Trump took office two weeks ago. Trump’s travel ban on visitors from seven majority-Muslim...